Abstract
Peptide microarrays have become increasingly accessible in recent years and as a result, more widely applied. Beyond its initial utility in substrate profiling, researchers are adopting peptide microarrays for the comparative screening of many different classes of enzymes, proteins/ proteomes and even living cells. Understanding the basis of peptide interactions at these diverse levels provides an unprecedented window into dissecting the complex cellular circuitries and molecular architectures of living systems. The peptides on the arrays may serve to sense protein activity (like substrates) or act as small molecule ligands (for potential therapeutic leads) in profiling, detection or diagnostic applications. This review will chart the progress made in peptide microarrays, with a focus on the recent advances that could impact how the field will be shaped in the coming years. These developments, along with the diminishing costs of library synthesis and growing commercial support, recognize that peptide microarrays will no longer remain just a vital research tool, but also a platform that could now be harnessed for wider drug discovery and point-of-care applications.
Keywords: Microarray, peptides, high-throughput screening, combinatorial chemistry, chemical biology, proteomics, affinity profiling, protein fingerprinting
Current Pharmaceutical Design
Title: Peptide Microarrays: Next Generation Biochips for Detection, Diagnostics and High-Throughput Screening
Volume: 14 Issue: 24
Author(s): Mahesh Uttamchandani and Shao Q. Yao
Affiliation:
Keywords: Microarray, peptides, high-throughput screening, combinatorial chemistry, chemical biology, proteomics, affinity profiling, protein fingerprinting
Abstract: Peptide microarrays have become increasingly accessible in recent years and as a result, more widely applied. Beyond its initial utility in substrate profiling, researchers are adopting peptide microarrays for the comparative screening of many different classes of enzymes, proteins/ proteomes and even living cells. Understanding the basis of peptide interactions at these diverse levels provides an unprecedented window into dissecting the complex cellular circuitries and molecular architectures of living systems. The peptides on the arrays may serve to sense protein activity (like substrates) or act as small molecule ligands (for potential therapeutic leads) in profiling, detection or diagnostic applications. This review will chart the progress made in peptide microarrays, with a focus on the recent advances that could impact how the field will be shaped in the coming years. These developments, along with the diminishing costs of library synthesis and growing commercial support, recognize that peptide microarrays will no longer remain just a vital research tool, but also a platform that could now be harnessed for wider drug discovery and point-of-care applications.
Export Options
About this article
Cite this article as:
Uttamchandani Mahesh and Yao Q. Shao, Peptide Microarrays: Next Generation Biochips for Detection, Diagnostics and High-Throughput Screening, Current Pharmaceutical Design 2008; 14 (24) . https://dx.doi.org/10.2174/138161208785777450
DOI https://dx.doi.org/10.2174/138161208785777450 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemical Phosphorylation of Histidine Residues in Proteins Using Potassium Phosphoramidate – a Tool for the Analysis of Acid-Labile Phosphorylation
Current Drug Delivery Metabolite Interference in Pharmacokinetic Studies
Drug Metabolism Letters Folate Targeted Solid Lipid Nanoparticles of Simvastatin for Enhanced Cytotoxic Effects of Doxorubicin in Chronic Myeloid Leukemia
Current Nanoscience Molecular Docking for Identification of Potential Targets for Drug Repurposing
Current Topics in Medicinal Chemistry Microarrays in Brain Research: Data Quality and Limitations
Current Genomics Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics
Current Gene Therapy ThermoTRP Channels in Nociceptors: Taking a Lead from Capsaicin Receptor TRPV1
Current Neuropharmacology Diagnosis Model of Paraquat Poisoning Based on Machine Learning
Current Pharmaceutical Analysis Analysis of Current Antifungal Agents and Their Targets within the Pneumocystis carinii Genome
Current Drug Targets Morphological Characterization of Lipid Structured Nanoparticles by Atomic Force Microscopy while Minimizing the Formation of Failed Artefacts
Current Nanomaterials Advances in Polyaniline for Biomedical Applications
Current Medicinal Chemistry Identification of Cancerlectins by Split Bi-profile Bayes Feature Extraction
Current Proteomics A Classification Method for Microarrays Based on Diversity
Current Bioinformatics Ex Vivo Models of HIV Sexual Transmission and Microbicide Development
Current HIV Research Bradykinin Receptors in Ischemic Injury
Current Neurovascular Research Thioredoxin from Escherichia coli as a Role Model of Molecular Recognition, Folding, Dynamics and Function
Protein & Peptide Letters An Overview of Olive Oil Biomolecules
Current Biotechnology Development and Applications of Fluorescent Oligonucleotides
Current Organic Chemistry Microwave-promoted One-pot Synthesis of Imidazo[1,2-a]pyridines in Lemon Juice
Current Microwave Chemistry Advancement Towards Tin-based Anticancer Chemotherapeutics: Structural Modification and Computer Modeling Approach to Drug-Enzyme Interactions
Current Topics in Medicinal Chemistry